Obayashi to Acquire Multiplex in $526M Expansion Deal 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Trump Says Anthropic No Longer Seen as National Security Threat 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly close to a $10 billion buyout deal with private equity firm Sycamore Partners, according to The Wall Street Journal. The deal, which could be finalized by Thursday, would take the struggling pharmacy chain private.
Sycamore is expected to offer between $11.30 and $11.40 per share in cash, with potential performance-based incentives. If the acquisition proceeds, Sycamore is likely to retain Walgreens' core U.S. retail operations while divesting or taking public other parts of the company.
Once a dominant force in U.S. pharmacy retail, Walgreens has seen its market value plummet from over $100 billion in 2015 to below $8 billion by late 2024. The company has struggled with declining prescription margins and an unsuccessful push into primary care. Under CEO Tim Wentworth, Walgreens has been closing underperforming stores in an effort to stabilize operations.
Sycamore, known for retail investments like its 2017 acquisition of Staples, aims to reposition Walgreens for long-term growth.
